These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2464111)

  • 1. Effect of vasoactive intestinal peptide on myocardial contractility and coronary blood flow in the dog: comparison with isoproterenol and forskolin.
    Anderson FL; Kralios AC; Hershberger R; Bristow MR
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):365-71. PubMed ID: 2464111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitization of myocardial but not coronary VIP receptor-mediated responses in dogs.
    Anderson FL; Kralios AC; Hershberger R; Bristow MR
    Am J Physiol; 1988 Sep; 255(3 Pt 2):H601-7. PubMed ID: 2843056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vagal nerve stimulation releases vasoactive intestinal peptide which significantly increases coronary artery blood flow.
    Feliciano L; Henning RJ
    Cardiovasc Res; 1998 Oct; 40(1):45-55. PubMed ID: 9876316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vagal nerve stimulation during muscarinic and beta-adrenergic blockade causes significant coronary artery dilation.
    Feliciano L; Henning RJ
    J Auton Nerv Syst; 1998 Jan; 68(1-2):78-88. PubMed ID: 9531447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct coronary vasodilation induced by intracoronary vasoactive intestinal peptide.
    Popma JJ; Smitherman TC; Bedotto JB; Eichhorn EJ; Said SI; Dehmer GJ
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):1000-6. PubMed ID: 1704974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vasoactive intestinal polypeptide on the canine cardiovascular system.
    Unverferth DV; O'Dorisio TM; Muir WW; White J; Miller MM; Hamlin RL; Magorien RD
    J Lab Clin Med; 1985 Nov; 106(5):542-50. PubMed ID: 4056568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glibenclamide prevents coronary vasodilation induced by beta 1-adrenoceptor stimulation in dogs.
    Narishige T; Egashira K; Akatsuka Y; Imamura Y; Takahashi T; Kasuya H; Takeshita A
    Am J Physiol; 1994 Jan; 266(1 Pt 2):H84-92. PubMed ID: 7905717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonmetabolically coupled coronary vasodilatation during inosine infusion in dogs.
    Jones CE; Mayer LR
    Am J Physiol; 1980 Apr; 238(4):H569-74. PubMed ID: 7377330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of flosequinan (BTS 49465) on myocardial oxygen consumption.
    Greenberg S; Touhey B; Paul J
    Am Heart J; 1990 Jun; 119(6):1355-66. PubMed ID: 2353621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nitric oxide synthesis reduces coronary blood flow response but does not increase cardiac contractile response to beta-adrenergic stimulation in normal dogs.
    Kaneko H; Endo T; Kiuchi K; Hayakawa H
    J Cardiovasc Pharmacol; 1996 Feb; 27(2):247-54. PubMed ID: 8720424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of nitric oxide on vascular, metabolic, and contractile responses to dobutamine in in situ canine hearts.
    Crystal GJ; Zhou X; Gurevicius J; Ramez Salem M
    Anesth Analg; 1998 Nov; 87(5):994-1001. PubMed ID: 9806671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart.
    Sawmiller DR; Henning RJ; Cuevas J; Dehaven WI; Vesely DL
    Neuropeptides; 2004 Oct; 38(5):289-97. PubMed ID: 15464194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of coronary blood flow, myocardial contractility, and heart rate on cardiac lymph circulation in open-chest dogs. Use of a direct cannulation method for subepicardial lymph vessel.
    Saito D; Hasui M; Shiraki T; Kono H
    Arzneimittelforschung; 1997 Feb; 47(2):119-24. PubMed ID: 9079229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intracoronary infusion of the vasoactive intestinal peptide antagonist [4Cl-D-Phe6-Leu17]VIP in the awake dog.
    Quebbemann BB; Rivier J; Bache RJ
    Peptides; 1991; 12(5):989-93. PubMed ID: 1800959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and coronary hemodynamic effects of pinacidil in awake normotensive and hypertensive dogs.
    Kawashima S; Liang CS
    Hypertension; 1985; 7(4):525-32. PubMed ID: 3891613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct effects of halothane on coronary blood flow, myocardial oxygen consumption, and myocardial segmental shortening in in situ canine hearts.
    Crystal GJ; Khoury E; Gurevicius J; Salem MR
    Anesth Analg; 1995 Feb; 80(2):256-62. PubMed ID: 7818110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary-administered urapidil does not influence myocardial contractility, metabolic activity, or coronary sinus blood flow in humans.
    van der Stroom JG; van Wezel HB; Piek JJ; Kal JE; van der Linden R; Vergroesen I; Pfaffendorf M; van Zwieten PA
    J Cardiothorac Vasc Anesth; 1999 Dec; 13(6):684-9. PubMed ID: 10622649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and coronary vasodilative properties of a selective and full beta 1-adrenoceptor agonist, T-0509, in comparison with isoproterenol in anesthesized dogs.
    Yamazaki J; Sugimoto T; Yabana H; Nagao T
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):209-15. PubMed ID: 7526052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right and left ventricular O2 uptake during hemodilution and beta-adrenergic stimulation.
    Crystal GJ; Kim SJ; Salem MR
    Am J Physiol; 1993 Nov; 265(5 Pt 2):H1769-77. PubMed ID: 8238590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal polypeptide facilitates atrioventricular nodal conduction and shortens atrial and ventricular refractory periods in conscious and anesthetized dogs.
    Rigel DF; Lathrop DA
    Circ Res; 1990 Dec; 67(6):1323-33. PubMed ID: 2245498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.